Golden
Hyasynth Bio

Hyasynth Bio

A biology company based in Montreal, Canada with a main focus on engineering microbes for the manufacturing of pharmaceuticals and other products, specifically cannabinoids including THC.



Instead of growing plants to make cannabinoids, Hyasynth engineer strains of yeast to produce it. After the yeast strains grows, they isolate pure cannabinoids for research, or for products like oils and pills.



Hyasynth is a Licensed Dealer under the Narcotic Control Regulations of Health Canada. Under these regulations, Hyasynth is permitted to produce and distribute cannabinoid products to those that are also legally allowed to possess cannabinoid products.



Their stated goal is to create a new way of producing cannabinoids that doesn't depend on growing plants or doing synthetic chemistry.



There are many cannabinoids, terpenes and combinations of these compounds.



Hyasynth has raised over $1M. The lead investors were Anges Quebec, a local angel network that put in $392,000 from its members and their first round of investors, which include SOSV, Ethan O. Perlstein (CEO of Perlara), and Andrew Hessel from Autodesk.

Timeline

People

Name
Role
LinkedIn

Alex Campbell

Founder



Andrew Hessel

Investor



Andrew Hessel

Advisor



Bill Liao

Advisor



Ethan O. Perlstein

Investor



Ethan O. Perlstein

Advisor



Jesse Rasch

Investor



Julien Saulgrain

Attorney



Kevin Chen

Founder



Nuzhat Tam-Zaman

Advisor



Rajeev Krishnan

Investor



Rajeev Surati

Investor



Shoham Mookerjee

Founder



Tariq Warsi

Advisor



Zach Wiltshire

Founder



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References